Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Elastin-Specific Molecular Magnetic Resonance Imaging Reveals Spatiotemporal Extracellular Matrix Remodeling at the Tumor-Stroma Interface During Prostate Cancer Progression.

Investigative radiology·2026
Same author

An Angiotensin II Receptor Blocker Suppresses Glucose-Induced Oxidative Stress in Human Rotator Cuff-Derived Cells.

Journal of orthopaedic research : official publication of the Orthopaedic Research Society·2026
Same author

Can trained behavior serve as tool for welfare assessment? A pilot study in a cancer model with Wistar rats.

Laboratory animals·2026
Same author

Topical vascular organoid therapy promotes microvascular regeneration and functional recovery in porcine ischemic cardiomyopathy.

Stem cell reports·2026
Same author

Emerging Theranostic Radiometals (<sup>149</sup>Tb, <sup>44</sup>Sc, <sup>52</sup>Mn, <sup>203</sup>Pb, <sup>55</sup>Co)-Decay Diversity, Production Landscape, and Translational Imaging.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

Biomimetic Dual-Multivalent Strategy Enabled <i>In Vivo</i> Tumor-Targeted Molecular MRI.

Analytical chemistry·2026

Related Experiment Video

Updated: Jun 14, 2025

Far-Red Fluorescent Senescence-Associated &#946;-Galactosidase Probe for Identification and Enrichment of Senescent Tumor Cells by Flow Cytometry
14:01

Far-Red Fluorescent Senescence-Associated β-Galactosidase Probe for Identification and Enrichment of Senescent Tumor Cells by Flow Cytometry

Published on: September 13, 2022

4.6K

MRI detection of senescent cells in porcine knee joints with a β-galactosidase responsive Gd-chelate.

Kerem Nernekli1, Dilyana B Mangarova1, Vidyani Suryadevara1

  • 1Molecular Imaging Program at Stanford (MIPS), Department of Radiology, Stanford University School of Medicine, Stanford, CA 94305 USA.

Npj Imaging
|May 7, 2025
PubMed
Summary

Senescent cells drive osteoarthritis. A novel MRI contrast agent detects these cells via beta-galactosidase (β-gal) activity, offering a new tool for diagnosis and treatment monitoring.

Keywords:
Bone imagingMagnetic resonance imagingMolecular imaging

More Related Videos

SA-&#946;-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
07:39

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs

Published on: June 28, 2019

23.8K
Evaluation of Injury-induced Senescence and In Vivo Reprogramming in the Skeletal Muscle
09:14

Evaluation of Injury-induced Senescence and In Vivo Reprogramming in the Skeletal Muscle

Published on: October 26, 2017

9.5K

Related Experiment Videos

Last Updated: Jun 14, 2025

Far-Red Fluorescent Senescence-Associated &#946;-Galactosidase Probe for Identification and Enrichment of Senescent Tumor Cells by Flow Cytometry
14:01

Far-Red Fluorescent Senescence-Associated β-Galactosidase Probe for Identification and Enrichment of Senescent Tumor Cells by Flow Cytometry

Published on: September 13, 2022

4.6K
SA-&#946;-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
07:39

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs

Published on: June 28, 2019

23.8K
Evaluation of Injury-induced Senescence and In Vivo Reprogramming in the Skeletal Muscle
09:14

Evaluation of Injury-induced Senescence and In Vivo Reprogramming in the Skeletal Muscle

Published on: October 26, 2017

9.5K

Area of Science:

  • Biomedical Imaging
  • Cellular Biology
  • Osteoarthritis Research

Background:

  • Senescent cells contribute to osteoarthritis (OA) pathogenesis by releasing inflammatory factors.
  • Senescence-associated beta-galactosidase (β-gal) is a biomarker for senescent cells, but in vivo detection is difficult.
  • Current methods for senescent cell detection in OA are limited, hindering targeted therapies.

Purpose of the Study:

  • To evaluate a novel β-gal responsive gadolinium (Gd) chelate for non-invasive detection of senescent cells using clinical MRI.
  • To assess the probe's efficacy in vitro, ex vivo, and in vivo in a preclinical porcine model of osteoarthritis.

Main Methods:

  • Development and testing of a β-gal responsive Gd-chelate contrast agent.
  • In vitro experiments using senescent and viable mesenchymal stromal cells (MSCs).
  • In vivo studies involving intraarticular injection into porcine knee joints with induced cartilage defects, followed by MRI analysis.

Main Results:

  • Senescent MSCs showed significant MRI signal enhancement with the Gd-chelate in vitro compared to control cells.
  • In vivo, the probe localized to cartilage defects and was activated by senescent cells, indicated by increased R1 relaxation rates.
  • MRI successfully detected β-gal expressing senescent cells in porcine joints.

Conclusions:

  • MRI with a β-gal responsive Gd-chelate can non-invasively detect senescent cells in vivo.
  • This approach shows potential for identifying OA patients who may benefit from senolytic therapies.
  • The technology could enable personalized treatment strategies and real-time monitoring of therapeutic responses.